
AFFINITY ASSET ADVISORS, LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | OVID | 10.64M | $23.61M |
![]() | ERAS | 5.35M | $86.56M |
![]() | LXEO | 5.05M | $28.99M |
![]() | IBIO | 3.11M | $5.90M |
![]() | ROIV | 2.80M | $77.56M |
![]() | ZURA | 2.56M | $15.26M |
![]() | SVRA | 2.51M | $13.72M |
![]() | PRQR | 2.45M | $3.98M |
![]() | TRVI | 2.00M | $23.86M |
![]() | XENE | 1.68M | $97.40M |
![]() | EPRX | 1.59M | $11.50M |
![]() | RZLT | 1.55M | $4.72M |
![]() | WVE | 1.40M | $10.16M |
![]() | CNTA | 1.40M | $55.61M |
![]() | TEVA | 1.40M | $42.17M |
![]() | ALKS | 1.35M | $47.74M |
![]() | AVTX | 1.34M | $20.02M |
![]() | APGE | 1.28M | $108.15M |
![]() | SYRE | 1.28M | $64.52M |
![]() | EQ | 1.23M | $2.45M |

Ovid Therapeutics Inc.
OVID
Shares Held
10.64M
Value
$23.61M

Erasca, Inc.
ERAS
Shares Held
5.35M
Value
$86.56M

Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
5.05M
Value
$28.99M

iBio, Inc.
IBIO
Shares Held
3.11M
Value
$5.90M

Roivant Sciences Ltd.
ROIV
Shares Held
2.80M
Value
$77.56M

Zura Bio Limited
ZURA
Shares Held
2.56M
Value
$15.26M

Savara Inc.
SVRA
Shares Held
2.51M
Value
$13.72M

ProQR Therapeutics N.V.
PRQR
Shares Held
2.45M
Value
$3.98M

Trevi Therapeutics, Inc.
TRVI
Shares Held
2.00M
Value
$23.86M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
1.68M
Value
$97.40M

Eupraxia Pharmaceuticals Inc.
EPRX
Shares Held
1.59M
Value
$11.50M

Rezolute, Inc.
RZLT
Shares Held
1.55M
Value
$4.72M

Wave Life Sciences Ltd.
WVE
Shares Held
1.40M
Value
$10.16M

Centessa Pharmaceuticals plc
CNTA
Shares Held
1.40M
Value
$55.61M

Teva Pharmaceutical Industries Limited
TEVA
Shares Held
1.40M
Value
$42.17M

Alkermes plc
ALKS
Shares Held
1.35M
Value
$47.74M

Avalo Therapeutics, Inc.
AVTX
Shares Held
1.34M
Value
$20.02M

Apogee Therapeutics, Inc.
APGE
Shares Held
1.28M
Value
$108.15M

Spyre Therapeutics, Inc.
SYRE
Shares Held
1.28M
Value
$64.52M

Equillium, Inc.
EQ
Shares Held
1.23M
Value
$2.45M
